Atul Saran's most recent trade in Emergent Biosolutions Inc was a trade of 971 Common Stock done at an average price of $12.4 . Disclosure was reported to the exchange on Feb. 28, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Emergent Biosolutions Inc | Atul Saran | EVP, Chief Strat & Dev Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.38 per share. | 28 Feb 2023 | 971 | 86,645 (0%) | 0% | 12.4 | 12,021 | Common Stock |
| Emergent Biosolutions Inc | Atul Saran | EVP, Chief Strat & Dev Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.71 per share. | 23 Feb 2023 | 845 | 87,616 (0%) | 0% | 13.7 | 11,585 | Common Stock |
| Emergent Biosolutions Inc | Atul Saran | EVP, Chief Strat & Dev Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.30 per share. | 23 Feb 2023 | 365 | 88,461 (0%) | 0% | 14.3 | 5,220 | Common Stock |
| Emergent Biosolutions Inc | Atul Saran | EVP, Chief Strat & Dev Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.25 per share. | 08 Feb 2023 | 2,051 | 88,826 (0%) | 0% | 13.3 | 27,176 | Common Stock |
| Emergent Biosolutions Inc | Atul Saran | EVP, Chief Strat & Dev Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 95 | 90,877 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Atul Saran | EVP, Chief Strat & Dev Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 38,664 | 38,664 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Atul Saran | EVP, Chief Strat & Dev Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 31,417 | 74,630 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Atul Saran | EVP, Chief Strat & Dev Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 16,916 | 91,546 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Atul Saran | EVP, Chief Strat & Dev Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.64 per share. | 28 Feb 2022 | 764 | 90,782 (0%) | 0% | 39.6 | 30,285 | Common Stock |
| Emergent Biosolutions Inc | Atul Saran | EVP, Corp Dev, GC & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.47 per share. | 23 Feb 2022 | 857 | 43,213 (0%) | 0% | 42.5 | 36,397 | Common Stock |
| Emergent Biosolutions Inc | Atul Saran | EVP, Corp Dev, GC & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.23 per share. | 23 Feb 2022 | 442 | 44,070 (0%) | 0% | 42.2 | 18,666 | Common Stock |
| Emergent Biosolutions Inc | Atul Saran | EVP, Corp Dev, GC & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.23 per share. | 22 Feb 2022 | 2,084 | 44,512 (0%) | 0% | 42.2 | 88,007 | Common Stock |
| Emergent Biosolutions Inc | Atul Saran | EVP, Corp Dev, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 1,836 | 46,596 (0%) | 0% | 0 | Common Stock |